Company Filing History:
Years Active: 2017-2022
Title: Ruben Vardanyan: Innovator in Opioid Receptor Modulation
Introduction
Ruben Vardanyan is a notable inventor based in Tucson, Arizona, recognized for his contributions to the field of pharmaceutical innovations. He holds a total of four patents, focusing primarily on compounds that modulate opioid receptors and their applications in treating various clinical conditions.
Latest Patents
One of his latest patents is titled "Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same." This invention provides a method for using a substituted 1-arylalkyl-4-acylaminopiperidine compound to treat a range of clinical conditions, including hemorrhagic shock, nicotine withdrawal symptoms, gastrointestinal side effects of opioids, cancer therapy, epithelial wounds, herpes zoster infection, and opioid-induced pruritus. The compound is characterized by specific structural formulas that enhance its therapeutic efficacy. Another significant patent involves "Opioid receptor modulators," which presents compounds capable of modulating opioid receptors, including μ- and/or δ-opioid receptors. These compounds are designed to reduce the likelihood of addiction or abuse compared to conventional opioid ligands, such as morphine.
Career Highlights
Ruben Vardanyan has had a distinguished career, working with esteemed institutions such as the University of Arizona and the Arizona Board of Regents on behalf of the University of Arizona. His work has significantly advanced the understanding and treatment of conditions related to opioid use and withdrawal.
Collaborations
He has collaborated with notable individuals in his field, including Victor J. Hruby, enhancing the impact of his research and innovations.
Conclusion
Ruben Vardanyan's innovative work in opioid receptor modulation and his contributions to pharmaceutical science underscore his importance as an inventor. His patents reflect a commitment to addressing critical health issues through scientific advancement.